Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Yunqiang ZhangJingxin DingKeqin HuaPublished in: The Journal of international medical research (2022)
For stage II SCNEC patients, FIGO 2009 underestimated the prognosis, while FIGO 2018 was more accurate. For stage IIIC, FIGO 2018 might be more individualized and accurate after combining stage IIIC with tumor local invasion.
Keyphrases
- end stage renal disease
- high resolution
- ejection fraction
- chronic kidney disease
- newly diagnosed
- single cell
- lymph node
- prognostic factors
- cell therapy
- big data
- electronic health record
- pet ct
- patient reported outcomes
- machine learning
- preterm birth
- cell migration
- artificial intelligence
- patient reported
- deep learning